Sangamo Therapeutics, Inc.

NASDAQ:SGMO

Biotechnology

Healthcare
$0.18 +2.06%

+$0.00 today

Market cap
$70.43M
Beta
1.29
P/E (TTM)
-0.5
EPS (TTM)
-$0.32
52W Low $0.10High $0.77

Volume 0.61M

Average 9.53M

Price history

Sangamo Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-55.37%

Period high

$0.57

Period low

$0.10

Latest

$0.18

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4May 27, 2026May 27, 2026
4May 27, 2026May 27, 2026
4May 27, 2026May 27, 2026
4May 27, 2026May 27, 2026
4May 27, 2026May 27, 2026
SC 13GMay 15, 2026May 15, 2026
10-QMay 14, 2026May 14, 2026
8-KMay 14, 2026May 14, 2026
10-K/AApr 30, 2026Apr 29, 2026
8-KApr 29, 2026Apr 29, 2026
4Apr 23, 2026Apr 23, 2026
4Apr 23, 2026Apr 23, 2026
4Apr 3, 2026Apr 3, 2026
4Apr 3, 2026Apr 3, 2026
4Apr 3, 2026Apr 3, 2026

Competitors

Who does Sangamo Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about SGMO's filings, answered from its disclosures.

What is the latest SGMO filing?

The latest filing shown is 4 dated May 27, 2026.

How many recent filings does SGMO have?

Intrinsic Alpha currently shows 20 recent filings for SGMO.